Abstract
Inclusion complexation of carmoful (1-hexylcarbamoyl-5-fluorouracil, HCFU) with three cyclodextrins (α-, β- and γ-CyDs) were studied by solubility method and X-ray diffractometry. On the basis of the phase solubility diagrams, solid complexes of HCFU with α-, β- and γ-CyDs were obtained in the molar ratios (host:guest) of 2∶1, 1∶1 and 1∶1, respectively. The dissolution rate of HCFU from the solid complexes was much greater than that of HCFU itself (α-CyD > complex > β-CyD complex > γ-CyD complex > HCFU alone). The hydrolysis of HCFU was suppressed by β-CyD, while no appreciable inhibition was observed by α- and γ-CyDs. The rapid dissolving form of HCFU-CyD complexes was found to increase significantly the serum levels of the drug after oral administration to rabbits.
Similar content being viewed by others
References
A.Hoshi, M.Iigo, A.Nakamura, M.Yoshida, and K.Kuretani:Gann,67, 725–731 (1976).
Y.Koyama and Y.Koyama:Cancer Treatment Reports,64, 861–867 (1980).
T.Miura, T.Uchiyama, M.Takahashi, K.Yamamoto, S.Koizumi, K.Fukamatsu, and J.Saito:Iyakuhin Kenkyu,11, 73–81 (1980).
K.Uekama:Yakugaku Zasshi,101, 857–873 (1981).
J.Szejtli:Cyclodextrins and Their Inclusion Complexes, Akademiai Kiado, Budapest (1982).
W.Saenger:Angew. Chem. Int. Ed. Engl.,19, 344–362 (1980).
T.Higuchi and K.A. Connors:Adv. Anal. Chem. Instr.,4, 117–212 (1965).
H.Nogami, T.Nagai, and Y.Yotsuyanagi:Chem. Pharm. Bull.,17, 499–509 (1969).
N.Christophidis, G.Mihaly, F.Vajda, and W.Louis:Clin. Chem.,25, 83–86 (1979).
K.Uekama, T.Fujinaga, F.Hirayama, M.Otagiri, M.Yamasaki, H.Seo, T.Hashimoto, and M.Tsuruoka:J. Pharm. Sci.,72, 1338–1341 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kikuchi, M., Uemura, Y., Hirayama, F. et al. Improvement of some pharmaceutical properties of carmoful by cycrodextrin complexation. Journal of Inclusion Phenomena 2, 623–630 (1984). https://doi.org/10.1007/BF00662228
Issue Date:
DOI: https://doi.org/10.1007/BF00662228